I agree about LPCN being a potentially extremely valuable stock especially at these prices.
Remember, if phase 3 is going well for PTB, the FDA could potentially allow them to start selling the drug so long as phase 3 continues with positive results.
I'm not sure where the once a day pill is time or trial wise. They haven't said anything about it recently that I recall. All I know is, once they have the 3 a day pill approved, the once a day should be easier.